Neurocrine Biosciences, Inc. (BIT:1NBIX)
Italy · Delayed Price · Currency is EUR 133.55
-6.05 (-4.33%)
At close: Dec 5, 2025
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of €13.33 billion as of December 5, 2025. Its market cap has increased by 17.01% in one year.
Market Cap
13.33B
Enterprise Value
12.78B
Revenue
2.29B
Ranking
n/a
PE Ratio
36.54
Stock Price
€133.55
Market Cap Chart
Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 13.33B, an increase of 7,865.14%. That is a compound annual growth rate of 15.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 13.33B | -0.15% |
| Dec 31, 2024 | 13.35B | 13.98% |
| Dec 29, 2023 | 11.71B | 9.01% |
| Dec 30, 2022 | 10.74B | 51.23% |
| Dec 31, 2021 | 7.10B | -2.95% |
| Dec 31, 2020 | 7.32B | -17.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 102.35B |
| Intesa Sanpaolo | 97.57B |
| Enel SpA | 88.39B |
| Ferrari | 60.35B |
| Assicurazioni Generali | 51.25B |
| Eni S.p.A. | 48.84B |
| Stellantis | 30.08B |
| Leonardo S.p.a. | 27.21B |